Omalizumab Weight-Based Dosing Efficacy Trial
Omalizumab Weight-Based Dosing Efficacy Trial
Recruiting · NCT06943534 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omalizumab Weight-Based Dosing Efficacy Trial | Hypersensitivity, Immediate, allergic disease, food allergy, immune system disorder | Recruiting | Phase 2 | 2026-02-05 | NCT06943534 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| University of North Carolina at Chapel Hill | Chapel Hill | United States | 129 |
| University of Texas Southwestern | Dallas | United States | 73 |